THE MINIMED™ 670G HYBRID AUTOMATED INSULIN DELIVERY SYSTEM: SETTING THE RIGHT EXPECTATIONS

被引：4
|
作者：
Leelarathna, Lalantha
Thabit, Hood
机构：
[1] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Diabet Ctr, Manchester, Lancs, England
[2] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Fac Biol Med & Hlth, Manchester, Lancs, England
来源：
ENDOCRINE PRACTICE | 2018年 / 24卷 / 07期
关键词：
EXPERIENCE; ADULTS;
D O I：
10.4158/EP-2018-0242
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：698 / 700
页数：3
相关论文
共 50 条
  • [31] Overnight to Early-Morning Glycemic Outcomes in Children Using the MiniMed™ 670G Hybrid Closed-Loop (HCL) System
    Forlenza, Gregory P.
    Shulman, Dorothy I.
    Wood, Michael A.
    Bailey, Timothy S.
    Bode, Bruce W.
    Buckingham, Bruce
    Huang, Suiying
    Shin, John
    Lee, Scott W.
    Cordero, Toni L.
    Kaufman, Francine R.
    DIABETES, 2018, 67
  • [32] The MiniMed™ 670G Hybrid Closed-Loop (HCL) System and Patient-Reported Outcomes Concerning Quality of Life Measures
    Gopalakrishnan, Shweta
    Fogel, Catherine
    Mueckler, John
    DIABETES, 2018, 67
  • [33] EXPLORATORY ANALYSIS OF HYBRID CLOSED-LOOP ALGORITHM ADAPTATION DURING MINIMED™ 670G SYSTEM USE BY CHILDREN, ADOLESCENTS, AND ADULTS
    Shin, J.
    Liu, M.
    Chen, X.
    Huang, S. Huang
    Cordero, T.
    Lee, S.
    Kaufman, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A82 - A83
  • [34] Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system
    Goran Petrovski
    Fawziya Al Khalaf
    Judith Campbell
    Khalid Hussain
    Hannah Fisher
    Fareeda Umer
    Acta Diabetologica, 2020, 57 : 105 - 107
  • [35] TIME IN TARGET GLUCOSE RANGE AND GLYCATED HEMOGLOBIN LEVELS DURING THE MINIMED 670G SYSTEM PIVOTAL TRIALS
    Shin, J.
    Liu, M.
    Chen, X.
    Cordero, T.
    Lee, S.
    Kaufman, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A85 - A86
  • [36] Real-world use of the MiniMed™ 670G system by patients with type 1 or type 2 diabetes
    Lee, S. W.
    Shin, J.
    Chen, X.
    Nguyen, M. -H.
    Cordero, T. L.
    Kaufman, F. R.
    DIABETOLOGIA, 2018, 61 : S394 - S394
  • [37] Comparison of Six Months Experience on Hybrid Closed Loop MiniMed 670G System and Advanced Hybrid Closed Loop MiniMed 780G System Using a Structured Initiation Protocol in Children and Adolescents with Type 1 Diabetes
    Petrovski, Goran
    Campbell, Judith
    Alkhalaf, Fawziya
    Hussain, Khalid
    DIABETES, 2022, 71
  • [38] Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System
    Hsu, Liana
    Buckingham, Bruce
    Basina, Marina
    Ekhlaspour, Laya
    von Eyben, Rie
    Wang, Justin
    Lal, Rayhan A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (01) : 1 - 7
  • [39] MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy
    Saunders, Aria
    Messer, Laurel H.
    Forlenza, Gregory P.
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (10) : 845 - 853
  • [40] The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed 670G Hybrid Closed-Loop System
    Cordero, Toni L.
    Garg, Satish K.
    Brazg, Ronald
    Bailey, Timothy S.
    Shin, John
    Lee, Scott W.
    Kaufman, Francine R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (12) : 749 - 752
12345